Literature DB >> 9715575

The time course of visuospatial processing deficits in schizophrenia: an event-related brain potential study.

G Bruder1, J Kayser, C Tenke, E Rabinowicz, M Friedman, X Amador, Z Sharif, J Gorman.   

Abstract

Event-related brain potentials (ERPs) were recorded during a dot enumeration task so as to investigate electrophysiologic correlates of early visuospatial processing in schizophrenia. Twenty-eight patients having a diagnosis of schizophrenia (n = 19) or schizoaffective disorder (n = 9) and 28 controls were tested. Patients showed poorer dot enumeration than did controls and also had markedly reduced early negative ERPs, which began about 150 ms after stimulus onset at the peak of the N1 potential and reached its maximum about 275 ms at the N2 peak. The N1 reduction in patients was greatest over left parietal sites for stimuli in the right visual field. The marked N1 and N2 reductions in patients are supportive of models postulating deficits in early visuospatial attention and allocation of conceptual resources in schizophrenia.

Entities:  

Mesh:

Year:  1998        PMID: 9715575     DOI: 10.1037//0021-843x.107.3.399

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  19 in total

1.  Neuronal generator patterns of olfactory event-related brain potentials in schizophrenia.

Authors:  Jürgen Kayser; Craig E Tenke; Dolores Malaspina; Christopher J Kroppmann; Jennifer D Schaller; Andrew Deptula; Nathan A Gates; Jill M Harkavy-Friedman; Roberto Gil; Gerard E Bruder
Journal:  Psychophysiology       Date:  2010-11       Impact factor: 4.016

2.  ERP generator patterns in schizophrenia during tonal and phonetic oddball tasks: effects of response hand and silent count.

Authors:  Jürgen Kayser; Craig E Tenke; Roberto Gil; Gerard E Bruder
Journal:  Clin EEG Neurosci       Date:  2010-10       Impact factor: 1.843

3.  A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia.

Authors:  Isaac Schechter; Pamela D Butler; Maria Jalbrzikowski; Roey Pasternak; Alice M Saperstein; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

4.  A neurophysiological deficit in early visual processing in schizophrenia patients with auditory hallucinations.

Authors:  Jürgen Kayser; Craig E Tenke; Christopher J Kroppmann; Daniel M Alschuler; Shiva Fekri; Roberto Gil; L Fredrik Jarskog; Jill M Harkavy-Friedman; Gerard E Bruder
Journal:  Psychophysiology       Date:  2012-07-16       Impact factor: 4.016

5.  P3b amplitude is not reduced in abstinent alcoholics with a current MDD.

Authors:  George Fein; Valerie A Cardenas
Journal:  Alcohol       Date:  2017-07-18       Impact factor: 2.405

6.  Current source density (CSD) old/new effects during recognition memory for words and faces in schizophrenia and in healthy adults.

Authors:  Jürgen Kayser; Craig E Tenke; Christopher J Kroppmann; Shiva Fekri; Daniel M Alschuler; Nathan A Gates; Roberto Gil; Jill M Harkavy-Friedman; Lars F Jarskog; Gerard E Bruder
Journal:  Int J Psychophysiol       Date:  2009-12-06       Impact factor: 2.997

7.  Stimulus- and response-locked neuronal generator patterns of auditory and visual word recognition memory in schizophrenia.

Authors:  Jürgen Kayser; Craig E Tenke; Roberto B Gil; Gerard E Bruder
Journal:  Int J Psychophysiol       Date:  2009-03-09       Impact factor: 2.997

8.  Impaired response selection in schizophrenia: evidence from the P3 wave and the lateralized readiness potential.

Authors:  Steven J Luck; Emily S Kappenman; Rebecca L Fuller; Benjamin Robinson; Ann Summerfelt; James M Gold
Journal:  Psychophysiology       Date:  2009-04-06       Impact factor: 4.016

Review 9.  Pharmacological manipulation of human working memory.

Authors:  Deanna M Barch
Journal:  Psychopharmacology (Berl)       Date:  2004-01-30       Impact factor: 4.530

Review 10.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.